Showing 2,721 - 2,740 results of 2,756 for search '(( 5 ((ng decrease) OR (nn decrease)) ) OR ( 50 ((ng decrease) OR (nn decrease)) ))', query time: 0.40s Refine Results
  1. 2721
  2. 2722

    Recognition by the Cf-4 immune receptor and susceptibility to proteolytic degradation of the WT-<i>Cf</i>Avr4 and selected ChBD and (GlcNAc)<sub>6</sub>-binding mutants. by Nicholas K. Hurlburt (5688038)

    Published 2018
    “…<b>(C)</b> Treatment of the WT-<i>Cf</i>Avr4 and Q69N, N93A, D94A, and D102A mutants with 500 ng/μl subtilisin, digests the original full-length protein (blue arrows) to a smaller product that corresponds to the true mature form of <i>Cf</i>Avr4 (red arrows). …”
  3. 2723
  4. 2724

    A model for SOX9 control of differentiation phase–specific gene expression in growth plate chondrocytes. by Victor Y. L. Leung (198251)

    Published 2011
    “…<i>Col2a1</i> transcription may be maintained due to stabilization of SOX9 binding by SOX5/6 <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1002356#pgen.1002356-Han1" target="_blank">[15]</a>. …”
  5. 2725

    Additional file 1 of MDM2-amplified esophageal adenocarcinomas exhibit an activated metabolic and immunosuppressive phenotype with multiple potential therapeutic targets by Karl Knipper (15016346)

    Published 2025
    “…The column names are given the MDM2 amplification status of each sample (MDM2-amplified: MDM2 +; MDM2-non-amplified: NEG.; non tumor tissue: N.G). Additionally, the columns are labeled whether the tumor was treated neoadjuvant (Neoadjuvant) or primarily resected (Primary). …”
  6. 2726
  7. 2727
  8. 2728
  9. 2729
  10. 2730
  11. 2731
  12. 2732
  13. 2733
  14. 2734
  15. 2735
  16. 2736
  17. 2737
  18. 2738
  19. 2739
  20. 2740